In a recent article at the National Post of Ontario, Canada, they look at the some of the risks that are associated with outsourcing clinical trials to other countries. A few of the roadbumps could be: different culture with different standards, the application quality between the two different populations, and the treatment of patients. There have been a surge of clinical trials being conducted in different countries, India, China and Argentina. Read the full article here.
How has your company overcome these challenges? What advice do you have to other companies outsourcing their clinical trials?
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
June
(12)
- Innovation needed for biotechs
- Clinical trial shows hope for no more insulin inje...
- New software for clinical trials
- Finding patients in Phase I clinical trials
- Sigma-Alpha Moves Differently from Classic CROs Of...
- Meetings Drive Business
- Merck to cut jobs
- How do you pay the participants in your clinical t...
- Women in cancer clinical trials
- CROs 2009 Workshop Video
- Outsourcing challenges
- Novotech in Joint Venture with Indian CRO, Focuses...
-
▼
June
(12)
No comments:
Post a Comment